Mkts

Entera Bio Ltd.

NASDAQ: ENTX
$3.31+0.03 (+0.76%)
As of Nov 20, 9:30 AM ET

Key statistics

Day range
3.173.33
52-week range
0.914.20
Today
Open3.25
Previous close3.31
Volume468.9K
Valuation
Market cap533.94M
P/E ratio—
EPS (TTM)-0.35
Income & risk
Dividend / yield—
Beta1.47
Avg volume262.8K
Discussion

ENTX News

Stories mentioning ENTX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue0.000.000.000.0042.0082.0042.0057.00
Cost of Goods Sold0.000.000.000.0042.0082.0042.0048.00
Gross Profit0.000.000.000.000.000.000.009.00
Operating Expenses
Research & Development2,2511,7181,6431,5201,1231,2011,4771,086
Sales General & Admin128.0050.00122.00103.00123.0062.00134.00
Total Operating Expenses3,5393,0423,2562,6682,5632,3373,0212,174
Operating Income (Loss)(3,539)(3,042)(3,256)(2,668)(2,563)(2,337)(3,021)(2,165)
Interest Income
Interest Expense
Other Expense
Pretax Income(3,021)
Tax Provision0.00
Net Income (Loss)(3,505)(3,016)(3,200)(2,656)(2,567)(2,358)(3,021)(2,145)
Earnings Per Share (Basic)0.07(0.07)0.070.060.06(0.06)0.080.06
Earnings Per Share (Diluted)0.07(0.07)0.070.060.06(0.06)0.080.06
Weighted Average Shares Outstanding (Basic)47,75646,19147,09046,83743,37737,65037,64537,090
Weighted Average Shares Outstanding (Diluted)47,75646,19147,09046,83743,37737,65037,64537,090

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ENTX

Entera Bio Ltd. (NASDAQ: ENTX) is a stock listed on the Nasdaq Stock Market under the ticker symbol ENTX. It last traded at $3.31 (Nov 20, 2026, 9:30 AM ET), up 0.8% on the day. That gives Entera Bio a market capitalisation of $533.9M.

Over the past 52 weeks ENTX has traded between $0.9100 and $4.20.

Revenue for the quarter ended Mar 31, 2026 was $0; a net loss of $3.5M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026$0-$3.5M
Dec 31, 2025$0-$3.0M
Sep 30, 2025$0-$3.2M
Jun 30, 2025$0-$2.7M

From Entera Bio’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…